Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
acetaminophen + pamabrom + pyrilamine maleate is an over-the-counter combination medication used for the temporary relief of menstrual symptoms, including cramps, headache, backache, bloating, muscle pain, water-weight gain, and irritability[1][2][3][4][5][6]. It contains three active ingredients: - **Acetaminophen** is a pain reliever and antipyretic that works primarily by inhibiting prostaglandin synthesis in the central nervous system, reducing pain impulse generation and regulating body temperature via the hypothalamus[1][2][3][4][5]. - **Pamabrom** is a mild diuretic that increases urine output and helps reduce water retention and bloating[1][2][3][4][5]. - **Pyrilamine maleate** is a first-generation H1 histamine receptor antagonist (antihistamine) that reduces the effects of histamine, helps alleviate irritability with sedative properties, and may induce mild drowsiness[1][2][3][4][5]. This combination is not intended for use in children under 12, and its use is contraindicated in patients with allergy to any of the components, severe hepatic/renal impairment, or recent treatment with monoamine oxidase inhibitors[1][2][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on acetaminophen + pamabrom + pyrilamine maleate.